Abstract
Targeting farnesylation of Rhes induces lysosomal-mediated tau degradation and reduces tau pathology in mice with tauopathy.
Funding Information
  • National Science Foundation (ISS-0808772, ITR 0331697)
  • National Institutes of Health (1U54NS100717)
  • National Institutes of Health (1U54NS100717)
  • National Institutes of Health (R01AG056058)
  • National Institutes of Health (AG046374)
  • EMBO
  • Tau Consortium
  • Cohen Veterans Bioscience
  • Leo and Ann Charitable Trust

This publication has 70 references indexed in Scilit: